Nanocomposite plasters for the treatment of superficial tumors by chemo-photothermal combination therapy

par Qi W, Yan J, Sun H, Wang H
Publié 2018

Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients

par S.E. Aghahowa, R.I. Ozolua, E.E. Bafor, P. Obarisiagbon, A.O. Isah
Publié 2021

Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance.

par Mathurin Dorel, Bertram Klinger, Tommaso Mari, Joern Toedling, Eric Blanc, Clemens Messerschmidt, Michal Nadler-Holly, Matthias Ziehm, Anja Sieber, Falk Hertwig, Dieter Beule, Angelika Eggert, Johannes H Schulte, Matthias Selbach, Nils Blüthgen
Publié 2021

Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid

par Yao J, Li Y, Sun X, Dahmani FZ, Liu H, Zhou J
Publié 2014

Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy

par Maleki A, Lamba N, Ma L, Lee S, Schmidt A, Foster CS
Publié 2017

Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis

par Aya Al-Azawi, Shahrazad Sulaiman, Kholoud Arafat, Javed Yasin, Abderrahim Nemmar, Samir Attoub
Publié 2021

Combined Therapy with microRNA-Expressing <i>Salmonella</i> and Irradiation in Melanoma

par Wonsuck Yoon, Yongsung Park, Seunghyun Kim, Yongkeun Park, Chul Yong Kim
Publié 2021

Gold Nanoparticles Mediated Drug-Gene Combinational Therapy for Breast Cancer Treatment

par Shrestha B, Wang L, Zhang H, Hung CY, Tang L
Publié 2020

Filamentous fungal endophthalmitis: results of combination therapy with intravitreal amphotericin B and voriconazole

par Mithal K, Pathengay A, Bawdekar A, Jindal A, Vira D, Relhan N, Choudhury H, Gupta N, Gupta V, Koday NK, Flynn HW Jr
Publié 2015

Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance

par Mathurin Dorel, Bertram Klinger, Tommaso Mari, Joern Toedling, Eric Blanc, Clemens Messerschmidt, Michal Nadler-Holly, Matthias Ziehm, Anja Sieber, Falk Hertwig, Dieter Beule, Angelika Eggert, Johannes H. Schulte, Matthias Selbach, Nils Blüthgen
Publié 2021

Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency

par Katsunori Manaka, Junichiro Sato, Maki Takeuchi, Kousuke Watanabe, Hidenori Kage, Taketo Kawai, Yusuke Sato, Takuya Miyagawa, Daisuke Yamada, Haruki Kume, Shinichi Sato, Takahide Nagase, Taroh Iiri, Masaomi Nangaku, Noriko Makita
Publié 2021

BRD4-mediated repression of p53 is a target for combination therapy in AML

par Anne-Louise Latif, Ashley Newcombe, Sha Li, Kathryn Gilroy, Neil A. Robertson, Xue Lei, Helen J. S. Stewart, John Cole, Maria Terradas Terradas, Loveena Rishi, Lynn McGarry, Claire McKeeve, Claire Reid, William Clark, Joana Campos, Kristina Kirschner, Andrew Davis, Jonathan Lopez, Jun-ichi Sakamaki, Jennifer P. Morton, Kevin M. Ryan, Stephen W. G. Tait, Sheela A. Abraham, Tessa Holyoake, Brian Higgins, Xu Huang, Karen Blyth, Mhairi Copland, Timothy J. T. Chevassut, Karen Keeshan, Peter D. Adams
Publié 2021

Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer

par Alexandre F. Aissa, Abul B. M. M. K. Islam, Majd M. Ariss, Cammille C. Go, Alexandra E. Rader, Ryan D. Conrardy, Alexa M. Gajda, Carlota Rubio-Perez, Klara Valyi-Nagy, Mary Pasquinelli, Lawrence E. Feldman, Stefan J. Green, Nuria Lopez-Bigas, Maxim V. Frolov, Elizaveta V. Benevolenskaya
Publié 2021

СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA

par L. R. Mukhamadieva, G. A. Mavzyutova, R. M. Fazlyeva, N. R. Bikhmetova
Publié 2014

Changing the Treatment Paradigm for Hepatocellular Carcinoma Using Atezolizumab plus Bevacizumab Combination Therapy

par Masatoshi Kudo
Publié 2021

Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections

par Janine N. Copp, Daniel Pletzer, Alistair S. Brown, Joris Van der Heijden, Charlotte M. Miton, Rebecca J. Edgar, Michelle H. Rich, Rory F. Little, Elsie M. Williams, Robert E. W. Hancock, Nobuhiko Tokuriki, David F. Ackerley
Publié 2020

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles

par Joana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, Arnaud Machelart, Vincent Delorme, Giuseppina Salzano, Raffaella Iantomasi, Catherine Piveteau, Christophe J. Queval, Ok-Ryul Song, Marion Flipo, Benoit Deprez, Jean-Paul Saint-André, José Hureaux, Laleh Majlessi, Nicolas Willand, Alain Baulard, Priscille Brodin, Ruxandra Gref
Publié 2017

Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia

par Hetty E. Carraway, Sridhar A. Malkaram, Yana Cen, Aymen Shatnawi, Jun Fan, Hamdy E. A. Ali, Zakaria Y. Abd Elmageed, Thomm Buttolph, James Denvir, Donald A. Primerano, Tamer E. Fandy
Publié 2020

Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.

par Lucy C Okell, Chris J Drakeley, Teun Bousema, Christopher J M Whitty, Azra C Ghani
Publié 2008

Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar.

par Achuyt Bhattarai, Abdullah S Ali, S Patrick Kachur, Andreas Mårtensson, Ali K Abbas, Rashid Khatib, Abdul-Wahiyd Al-Mafazy, Mahdi Ramsan, Guida Rotllant, Jan F Gerstenmaier, Fabrizio Molteni, Salim Abdulla, Scott M Montgomery, Akira Kaneko, Anders Björkman
Publié 2007